Mustang Bio Inc.

1.35
-0.09 (-6.25%)
At close: Apr 03, 2025, 3:59 PM
1.30
-3.70%
After-hours: Apr 03, 2025, 05:15 PM EDT

Mustang Bio Statistics

Share Statistics

Mustang Bio has 3.31M shares outstanding. The number of shares has increased by -90.94% in one year.

Shares Outstanding 3.31M
Shares Change (YoY) -90.94%
Shares Change (QoQ) -94.35%
Owned by Institutions (%) 8.04%
Shares Floating 2.75M
Failed to Deliver (FTD) Shares 23
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 37.02K, so 2.86% of the outstanding shares have been sold short.

Short Interest 37.02K
Short % of Shares Out 2.86%
Short % of Float 3.31%
Short Ratio (days to cover) 0.08

Valuation Ratios

The PE ratio is -342.55 and the forward PE ratio is -0.24. Mustang Bio's PEG ratio is 3.44.

PE Ratio -342.55
Forward PE -0.24
PS Ratio 0
Forward PS 0.1
PB Ratio -1393.19
P/FCF Ratio -472.9
PEG Ratio 3.44
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Mustang Bio.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.68, with a Debt / Equity ratio of -0.23.

Current Ratio 0.68
Quick Ratio 0.68
Debt / Equity -0.23
Debt / EBITDA -0.05
Debt / FCF -0.08
Interest Coverage 3249

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-196.9K
Employee Count 80
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -96.51% in the last 52 weeks. The beta is 1.81, so Mustang Bio's price volatility has been higher than the market average.

Beta 1.81
52-Week Price Change -96.51%
50-Day Moving Average 2.48
200-Day Moving Average 11.31
Relative Strength Index (RSI) 33.4
Average Volume (20 Days) 240.76K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -16.25M
Net Income -15.75M
EBITDA -16.25M
EBIT -15.76M
Earnings Per Share (EPS) -0.03
Full Income Statement

Balance Sheet

The company has 6.84M in cash and 878K in debt, giving a net cash position of 5.96M.

Cash & Cash Equivalents 6.84M
Total Debt 878K
Net Cash 5.96M
Retained Earnings -396.72M
Total Assets 7.19M
Working Capital -8.98M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.41M and capital expenditures 0, giving a free cash flow of -11.41M.

Operating Cash Flow -11.41M
Capital Expenditures 0
Free Cash Flow -11.41M
FCF Per Share -0.02
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MBIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for MBIO is $100, which is 6893% higher than the current price. The consensus rating is "Buy".

Price Target $100
Price Target Difference 6893%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Apr 4, 2023. It was a backward split with a ratio of 1:15.

Last Split Date Apr 4, 2023
Split Type backward
Split Ratio 1:15

Scores

Altman Z-Score -88.74
Piotroski F-Score 2